Profile: Villoo Morawala Patell

Jayaraman, K. S.
July 2007
Nature Biotechnology;Jul2007, Vol. 25 Issue 7, p705
Academic Journal
The article profiles Villoo Morawala Pattell, chief executive officer (CEO) of biotechnology firm Avesthagen in Bangalore, India. Pattell started her business path at the International Crops Research Institute for Semi-Arid Tropics in 1980s. She earned the doctor of philosophy (PhD) studies in plant molecular biology at Louis Pasteur University. In addition, she has the committed to improve the biotechnology industry in the country.


Related Articles

  • Affymetrix microarray tech is set for Parsi genetic study.  // Medical Device Daily;3/25/2008, Vol. 12 Issue 58, p5 

    This article reports on an agreement signed by Santa Clara, California-based Affymetrix with Avesthagen Limited, a biotechnology company in Bangalore, India. Under the deal, the microarray technology of Affymetrix will be used for the AVESTAGENOME Project, a genetic study of Parsi individuals. A...

  • Women of influence. Walters, Kath // BRW;8/30/2007, Vol. 29 Issue 34, p112 

    The article features three Australian women executives, considered three of the most influential women in the Australian biotechnology sector. Amanda Caples is director of biotechnology for the state of Victoria. Jackie Fairley is chief executive of medical manufacture Starpharma. Carrie...

  • Women CEOs Proving It: Glass Ceiling Can Break. Hollingsworth, Catherine // BioWorld Today;6/22/2009, Vol. 20 Issue 118, p1 

    The article offers insights from a number of women chief executive officers (CEO) about their successful careers in the biotechnology industry. Anna Gluskin of Generex Biotechnology cites some career highlights and admits to experiencing personal sacrifices such as a couple of divorces in her...

  • Other News To Note.  // BioWorld International;12/15/2010, Vol. 15 Issue 49, p2 

    This section offers news briefs related to the biotechnology industry. Avesthagen Ltd. has manufactured its Avdesp biosimilar to dardepoetin alfa. A special protocol assessment agreement was signed by Bavarian Nordic AS with the U.S. Food and Drug Administration (FDA) for a study of Prostvac...

  • Cipla deal tied up. Tong, Alfred // Asian Chemical News;8/2/2004, Vol. 10 Issue 455, p8 

    Reports on an agreement between Cipla and Avesthagen Gengraine Technologies to develop biopharmaceuticals and biotechnological products in India. Impact of the implementation of international patent laws on pharmaceutical industry in the country; Significance of the deal to the companies; Terms...

  • THE MOST POWEFUL WOMEN IN CHICAGO BUSINESS.  // Crain's Chicago Business;9/1/2014, Vol. 37 Issue 45, p0018 

    The article focuses on the compilation of high-performing female chief executive officers (CEOs) in Chicago, Illinois.

  • Broadening the talent pool.  // Governance Newsletter;Mar2012, Issue 213, p4 

    The article announces a seminar series organized by City University London and the National Council for Voluntary Organizations (NCVO) in Great Britain from April to June 2012 for those female chief executives from the voluntary sector who are willing to serve on boards of private sector. ...

  • FAST FACTS. Gilpatrick, Kristin // Credit Union Management;Mar2001, Vol. 24 Issue 3, p14 

    Deals with the report from the `2000 Catalyst Census of Women Corporate Officers and Top Earners Among Fortune 500 Companies,' which deals with the presence of woman chief executives in various corporations.

  • Avesthagen Nutrition Unit takes bite out of global pie for DHA.  // BioSpectrum;Oct2013, Vol. 11 Issue 10, p16 

    The article reports that a licensing agreement has been announced by Avesthagen Ltd. for its 100 percent vegetarian Avesta DHA for animal feed application.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics